Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for liver failure
ChiCTR-IPR-14005669Phase 4Not yet recruiting
- Sponsor
- Liver Failure Treatment and Research Center
- Start
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of granulocyte colony-stimulating factor in hepatic failure (2 arms), sponsored by Liver Failure Treatment and Research Center. Primary endpoint: Survival rate. Planned start Nov 2013; status: not yet recruiting.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
hepatic failure
Beyond the preview
Go deeper on ChiCTR-IPR-14005669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005669.